首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >The pharmaceutical vial capping process: Container closure systems, capping equipment, regulatory framework, and seal quality tests
【24h】

The pharmaceutical vial capping process: Container closure systems, capping equipment, regulatory framework, and seal quality tests

机译:药物瓶盖盖过程:容器密闭系统,盖盖设备,法规框架和密封质量测试

获取原文
获取原文并翻译 | 示例
       

摘要

Parenteral drug products are protected by appropriate primary packaging to protect against environmental factors, including potential microbial contamination during shelf life duration. The most commonly used CCS configuration for parenteral drug products is the glass vial, sealed with a rubber stopper and an aluminum crimp cap. In combination with an adequately designed and controlled aseptic fill/finish processes, a well-designed and characterized capping process is indispensable to ensure product quality and integrity and to minimize rejections during the manufacturing process.
机译:肠胃外药物产品应通过适当的初级包装进行保护,以防止受到环境因素的影响,包括在保质期内可能受到的微生物污染。肠胃外药品最常用的CCS配置是玻璃小瓶,用橡胶塞和铝压盖密封。结合适当设计和控制的无菌灌装/抛光工艺,精心设计和表征的封盖工艺必不可少,以确保产品质量和完整性并最大程度地减少制造过程中的废品率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号